Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 237Lymphoma 176Lymphoma, Large B-Cell, Diffuse 171Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Lymphoma, Follicular 77Lymphoma, Non-Hodgkin 72Burkitt Lymphoma 66Multiple Myeloma 62Leukemia 58Hodgkin Disease 45Lymphoma, Mantle-Cell 41Neoplasms 35Lymphoma, T-Cell, Peripheral 31Lymphoma, B-Cell 30Lymphoma, B-Cell, Marginal Zone 27Lymphoma, Large-Cell, Anaplastic 26Lymphoma, Large-Cell, Immunoblastic 24Neoplasm Metastasis 23Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 22Neoplasms, Plasma Cell 21Recurrence 19Immunoblastic Lymphadenopathy 15Dendritic Cell Sarcoma, Interdigitating 15Lymphoma, T-Cell 14Leukemia, Biphenotypic, Acute 10Waldenstrom Macroglobulinemia 9Blast Crisis 9Primary Myelofibrosis 8Myelodysplastic Syndromes 8

Interventions

Nivolumab 3Ipilimumab 3poly ICLC 2Specimen Handling 2Sorafenib 2Irinotecan 2Cyclophosphamide 2spartalizumab 1sapanisertib 1pembrolizumab 1fludarabine 1durvalumab 1dostarlimab 1dehydroftorafur 1balstilimab 1atezolizumab 1aflibercept 1Whole-Body Irradiation 1Watchful Waiting 1Vincristine 1Tacrolimus 1Sunitinib 1Prednisone 1Platinum 1Oxaliplatin 1Observation 1Mycophenolic Acid 1Mesna 1Leuprolide 1Letrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fibrolamellar hepatocellular carcinoma × Prednisone × Clear all
NCT02702960 2018-06-15

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡